Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR mutations are more frequent in well-differentiated than in poor-differentiated lung adenocarcinomas.

Pathology oncology research : POR - 1 Dec 2008

Liu Yan, Xu Mei Lin, Zhong Hao Hao, Heng Wan Jie, Wu Bing Quan

Abstract excerpt

Somatic mutations in epidermal growth factor receptor (EGFR) tyrosine kinase domain, particularly deletions in exon 19 and point mutation in exon 21, are associated with clinical outcome in patients with lung adenocarcinoma, suggesting that EGFR mutation would have an important role in clinical d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Cisplatin

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Sex Factors

Source

Identifiers

PMID: 18985444
DOI: 10.1007/s12253-008-9113-1

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18985444-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR mutations are more frequent in well-differentiated than in poor-differentiated lung adenocarcinomas.PMID 18985444Read ↗

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma.Semantic proximity Read ↗

Prognostic implication of EGFR mutation status and subtype in resected lung adenocarcinoma patients irrespective of therapy.Semantic proximity Read ↗

Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smokingSemantic proximity Read ↗

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.Semantic proximity Read ↗

[Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].Semantic proximity Read ↗

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.Semantic proximity Read ↗

Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas.Semantic proximity Read ↗

Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients.Semantic proximity Read ↗

Histopathologic characteristics of pulmonary adenocarcinomas with and without EGFR mutation.Semantic proximity Read ↗

[Clinical characteristics and outcomes of lung cancer patients with EGFR mutations in exons 19 and 21].Semantic proximity Read ↗

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.Semantic proximity Read ↗

Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.